Learn due diligence best practices from leading global pharmaceutical professionals in this Q&A white paper on how to form productive biopharma partnerships.
This white paper discusses...
- What large pharma expects when entering due diligence with a biopharma company
- The importance of IP due diligence
- The best ways to present and stage information that is disclosed to a potential partner
- Common mistakes and how to avoid them
- How to recognize potential problems and address them early in the process
- The best practices for the best long-term partnerships
If you are seeking to partner with another biopharmaceutical company, or desire to out- or in-license a drug, you will want to hear these perspectives. Request a copy.